This trial is testing whether delivering radiation in higher doses over a shorter time period is more effective at treating prostate cancer with fewer side effects.
1 Primary · 12 Secondary · Reporting Duration: Up to 5 years
Active Control
Experimental Treatment
178 Total Participants · 2 Treatment Groups
Primary Treatment: Hypofractionated Radiation Therapy · No Placebo Group · Phase 3
Age 18+ · Male Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: